Angela G.

Angela G. has over 29 years of work experience in the pharmaceutical industry. Angela is currently the Director of Global Regulatory Strategy at Sun Pharma, a position they have held since 2020. Before that, they worked as the Director of Regulatory Affairs Strategy at Mitsubishi Tanabe Pharma Development America from 2018 to 2020. In 2018, Angela also briefly worked as a Principal at VisionPharma Consulting LLC.

Prior to these roles, Angela served as the Head of Regulatory Affairs- US at Sanofi from 2016 to 2018, where they were responsible for managing regulatory submissions and responding to FDA deficiency letters. From 2006 to 2016, they worked at Bristol-Myers Squibb, initially as the Director of Global Regulatory Therapeutic Area Lead, overseeing regulatory strategy and interactions with health authorities. Later, they held the position of Associate Director WWQC Regulatory CMC, where they focused on regulatory strategy for marketed products and change control.

Angela's extensive career in the pharmaceutical industry began in 1991 at Wyeth Lederle Spa as a Formulation Scientist. Angela later worked at Schein Pharmaceuticals as a Senior Regulatory Compliance Auditor from 1994 to 1997. Angela started their career at Pfizer Pharmaceuticals in 1997, where they held several roles, including Manager of Global Manufacturing Compliance and Corporate Quality Auditor.

Overall, Angela G. has a diverse background in regulatory affairs, strategy, compliance, and quality assurance within the pharmaceutical industry.

Angela G. earned a Masters in Pharmaceutics and a Bachelor of Science in Pharmacy from Long Island University.